|
Vivus tried again with FDA for weight-loss drug
San Jose Mercury News Drug developer Vivus Inc. has resubmitted an application for its potential weight-loss drug Qnexa to the Food and Drug Administration. The Mountain View, Calif., company said Monday the resubmission follows an agreement on filing strategy that it … VIVUS Resubmits Qnexa NDA to the FDA Vivus Resubmits FDA Application For Obesity Drug Qnexa Vivus resubmits FDA application for obesity drug |
Read the original post on weight loss – Google News